May 2, 2018 06:31 AM EDTUpdated 06:48 AM
Financing
Startups

Chi­nese in­vestors back Refuge Bio’s $25M B round as it steers gene en­gi­neer­ing tech to an IND

John Carroll

Editor & Founder

A group of Chi­nese in­vestors led by 3SBio and Se­quoia Chi­na are bankrolling the next leg of de­vel­op­ment at Refuge Biotech­nolo­gies, a Bay Area biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times